about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
8.41
0.80
(10.51%)
3.2M
XNAS Volume
XNAS 02 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..